Recent advances in bioactive microbial secondary metabolites.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000096:biosynthesis*; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D001419:Bacteria / Q000201:enzymology / Q000235:genetics / Q000378:metabolism*; D005075:Biological Evolution; D001761:Bleomycin / Q000494:pharmacology / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular / Q000187:drug effects; D007976:Leupeptins / Q000096:biosynthesis; D051379:Mice; D008970:Molecular Weight; D010957:Plasmids; D013302:Streptomyces / Q000378:metabolism
D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D004791:Enzyme Inhibitors; D007976:Leupeptins; D001761:Bleomycin